How sham patents are hurting the pharma industry
The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.
The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.
GSK, Lundbeck, and ROVI share how their events strategies contribute to higher-value engagement with healthcare professionals (HCPs). By Jenna Sherlock-Goudet, Veeva's Director of Commercial Strategy, Europe.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
NIH team develops AI tool to predict cancer drug response
TetraScience and Google Cloud link for AI-driven drug developments
Bayer and Google Cloud to develop AI solutions for radiologists
Q&A: BARDA wants to back tech that can combat multiple infections, says director